Valve deterioration associated with higher risk of death, rehospitalization
Patients who underwent transcatheter aortic valve replacement (TAVR) with a supra-annular self-expanding transcatheter heart valve (THV) showed significantly less structural valve deterioration (SVD) after 5 years than their counterparts who underwent surgical aortic valve replacement (SAVR), a new analysis of two randomized trials shows.